Other board talking about doctors interested in this

New Post Public Reply Private Reply Replies (0) Message Board
joey68
Other board talking about doctors interested in this technology. Very nice. Now... let's slap on some DD gear and see how deep this really goes!

Keep in mind, the following stuff is only one year old; not outdated; not a relic.

Here we go:

links will probably only work from original post

The WavSTAT4 mentioned at the Medical Technologies Advisory Committee:

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE
Medical Technologies Advisory Committee (MTAC)
Minutes of the 49th meeting on 19 March 2015

Here's a link (seeing naysayers never provide links, id say this is some serious stuff)
Medical Technologies Advisory Committee

Scroll down to Page 4 of 5..

Quote:
10. MT264 The WavSTAT 4 optical biopsy system for the real time histological assessment of colon polyps in vivo
Prof Venkataraman Subramanian declared a non-personal interest for this technology. Dr James East declared a personal pecuniary and non-personal interest for this technology.
The Committee was asked if there were any specific equality issues to consider in relation to this technology.
Introduced by Brian Selman, Venkataraman Subramanian and James East.
The Committee then considered the technology for selection and routing


"Joey68," you may be asking, "..what's the point you're trying to make here?"..

Notice the quote mentions Dr James East.

Now notice the quote mentions he "declared a personal pecuniary interest"

Do you know what 'Pecuniary' means?

Pecuniary = money / financial. Which means he has some sort of financial interest in this product . It doesnt say he has a personal interest. It says he has a financial interest.

Not only this, but recognize who he is:
Dr James East is an important person in the field of Gastroenterology.

https://www.linkedin.com/in/james-east-6057aa...uthor_name

Quote:
Cellular immunology, In vivo imaging and SNP typing

Wait a sec...the WavSTAT4 does in vivo imaging. Cray-cray, right?
http://www.expmedndm.ox.ac.uk/tgu/principal-investigators

So, you've read in other posts people saying doctors are interested in this product, but now, not only do you see for yourself that this doctor is interested, Dr. James East, the Honorary Senior Clinical Lecturer at the Translational Gastroenterology Unit, in John Radcliffe Hospital is also interested.

In addition, out of all the other competitors, I can only find his interest in Spectrascience's technology.

Oh ya, remember a previous post about how the UK / NHS is trailing behind in cancer research and has a 5 year program currently underway to catch up with the rest of the world?

Just so happens Dr James East works with the NHS . Coincidence? I doubt it. I believe the UK is getting ready to use the WavSTAT4 as a way to tell the world, "Hey look guys! We recognize we've been slacking in cancer research for decades but we just got our hands on the WavSTAT4, which will not only catch us up, but we'll surpass everyone else not using a WavSTAT."

Again, nay-sayers, any response less than actual links disproving any of the above statements is a waste of time and will be disregarded as 'blubbers'.

BOOM.

SpectraSCIENCE Inc. (SCIE) Stock Research Links

SCIE Board Company Profile Buy Rating Time & Sales News Filings Financials
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Everest Group Faces Class Action: Key Deadlines Looming

Updated Category News Views 110

Everest Group's Legal Quagmire: A Rocky Road Ahead Riding high has its pitfalls. I mean just take a gander at Everest Group, Ltd. (NYSE: EG). The suits and stocks got their knickers in a twist when the company's missteps saw them landing smack dab in the middle of a shareholder class-action lawsuit. It's gloomy days, my friend, especially if you're carrying a portfolio...

Continue Reading
Generational Happiness: Keio Study Shakes Norms

Updated Category News Views 61

Happiness Across Generations: New Light from Japan Think happiness is just a personal journey? Well, it turns out there's more to the story when you dive into family ties. A study from Keio University in Japan shakes things up by finding that happiness has a unique way of passing down from parent to child, showing a stronger grip across generations than general or mental...

Continue Reading
HanAll F&B Pioneers New Path for Domestic Rice Noodles

Updated Category News Views 128

New Spin on an Old Favorite: Rice Noodles Forget about the same old wheat noodles clogging up the pantry. HanAll F&B is revamping the noodle game with a homegrown twist, setting sights on a future where Korean rice isn't just for steaming, soup, or sushi. This outfit from Taebaek, Gangwon, has got its hands deep in the rice flour, finessing a patent that aims to make...

Continue Reading
Chemours Class Action: Key Deadline Approaches Fast

Updated Category News Views 56

A Rocky Ride for Chemours Investors The ticker might read NYSE:CC, but right now, that might as well stand for "Caution, Cautious," if you ask me. Investors are on high alert with Chemours facing a class action lawsuit, and the stakes couldn’t be higher. Deadline's looming on December 7, 2026, for those gunning for lead plaintiff status. It's a tense time for anyone who...

Continue Reading
Purina's Docuseries Wins Big at Daytime Emmys

Updated Category News Views 89

Unleashing a Winning Streak Forget stock price fluctuations—Purina Films has struck gold. In a world where brand stories often fall flat or feel contrived, Purina's 'A Different Breed' docuseries just bagged three Daytime Emmy® Awards. It's not every day you see corporate storytelling make a splash like this, but when you blend pets and riveting narratives, magic...

Continue Reading
PG&E's $500K Grants Wrap Up Five-Year Environmental Push

Updated Category News Views 246

Wrapping Up a Half-Decay of Environmental Commitment PG&E has been playing the long game with its environmental initiatives, and this wraps up a five-year saga that's worth dissecting. The PG&E Corporation Foundation has doled out its final set of grants, making a 25-strong lineup of eco-friendly campaigns. We're talking $500,000 split among five organizations trying to...

Continue Reading
Langford Chosen for Navy Mutual's 2026 Bolles Award

Updated Category News Views 39

Awarding a Military Financial Educator There's something profoundly rewarding when hard work and dedication get their due recognition. That's precisely what's happened for Lacey Langford, who’s just been awarded the Lieutenant Timothy Dix Bolles Excellency in Education Award by the Navy Mutual Aid Association, or simply Navy Mutual. This isn’t just some...

Continue Reading
Investigation of Maplebear Sale to DoorDash Sparks Debate

Updated Category News Views 174

Shareholders Fret Over Maplebear's Proposed Transaction It ain't every day a deal's got shareholders fidgeting more than a cat in a dog park, but here we are. Maplebear Inc. (NASDAQ: CART) finds itself under the magnifying glass as the seasoned crew over at Monteverde & Associates PC sound the alarm bells. The firm, sitting cozy in the Empire State Building, is on the...

Continue Reading
Springbrook's AI Push: Transforming Local Governance

Updated Category News Views 116

Revolutionizing Government Tech with AI Springbrook Software is positioning itself as a frontrunner in modernizing government tech, unveiling a suite of AI-driven innovations under its Cirrus ERP platform. During their recent conference, Activate 2026, held in Orlando, the commitment to transforming how local governments operate was clear. With new tools like AI Invoicing...

Continue Reading
Conquering Dental Anxiety: Tips for a Calm Visit

Updated Category News Views 29

Breaking the Fear of the Dentist's Chair There's no sugar-coating it—hitting the dental chair can feel like gearing up for a bout in the boxing ring, especially if anxiety's already taken root. But listen, it doesn't have to be that way, and that's where HelloNation's recent feature steps in. Dr. Adriane Lippian and Dr. Jim Lippian, dentists hailing from Texarkana,...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation of iRobot Corporation Sparks Legal Interest

Updated Category News Views 122

Understanding the Investigation into iRobot Corporation Recently, the national securities law firm Faruqi & Faruqi, LLP has begun investigating potential claims on behalf of shareholders of iRobot Corporation (NASDAQ: IRBT). This investigation has been prompted by concerns regarding the company’s financial disclosures and business strategies. Who Should be Concerned? If...

Continue Reading
Congruence Therapeutics Celebrated as a Fierce Leader in 2025

Updated Category News Views 125

Congruence Therapeutics Recognized in the Fierce 15 for 2025 Congruence Therapeutics, a biotechnology firm dedicated to innovative treatments for diseases linked to protein misfolding, recently celebrated a significant distinction as one of the Fierce 15 biotechnology companies for the year 2025. This esteemed accolade from Fierce Biotech highlights Congruence as one of...

Continue Reading
Transforming Trade Shows: The ExpoGroup Launches ExpoPortal

Updated Category News Views 190

Transforming the Exhibitor Experience with Innovation The Expo Group has unveiled its exciting new platform, ExpoPortal, aimed at enhancing the trade show experience for exhibitors. This innovative solution replaces their previous online system, CyberServices, which served its purpose well but has now been revitalized to meet the modern needs of exhibitors across various...

Continue Reading
Exploring Growth in the IoT Identity Access Management Sector

Updated Category News Views 103

Understanding the IoT Identity and Access Management Market In recent years, the IoT identity and access management market has become a focal point for businesses aiming to bolster their security measures in an increasingly digital world. Current reports indicate that the market is expected to see a remarkable growth trajectory, elevating from USD 5.44 billion in the...

Continue Reading
Major Insider Purchase by Christopher L Mapes at Nordson

Updated Category News Views 130

Significant Insider Purchase at Nordson In a notable move within the corporate landscape, Christopher L Mapes, who serves as the Director at Nordson (NASDAQ: NDSN), recently made a considerable investment in the company. According to recent filings, Mapes purchased 930 shares of Nordson, amounting to an impressive total of $215,713. This proactive step signals a strong...

Continue Reading